This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $11,957.15, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 26, 2024. The contract has a completion date of September 27, 2024 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical for a comprehensive range of medical commodities, and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation for medical products and prescription drugs. These IDCs enable government agencies to efficiently procure essential pharmaceutical and medical supplies from AmerisourceBergen to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 12/26/24, 9:01 AM